January 2024

Technical Program

Technical Program Events to be held at mHub unless otherwise specified. See the Conference Venue page for more information Browse Featured Startup Companies Day 1 Tuesday, August 6 8:45 AM 9:15 AM Badge Pickup (mHUB 2nd floor) & Morning Coffee, tea & fruit 9:15 AM 9:30 AM Welcoming Remarks...

Read more about Technical Program

Brenntag North America, Inc.

Read more about Brenntag North America, Inc.

Become a Sponsor or Exhibitor at the Annual Meeting 2024

Fill out the following form to download the sponsor and exhibitor prospectus.

Read more about Become a Sponsor or Exhibitor at the Annual Meeting 2024

Kahina Lang

Kahina is currently responsible for building a collaboration platform to unlock new ways to expand the applicability of mRNA-based medicines. This cross-sector effort will advance Merck KGaA Darmstadt Germany’s offerings for the mRNA market via novel lipid nanoparticle formulation and potentially add therapeutic modalities to the Healthcare pipeline. With a proven track record of advancing cross-functional projects, Kahina has been a driving force of this cross-sector initiative from its origin, bringing to life the One Merck vision and making innovation...Read more

Read more about Kahina Lang

Carrie Simms

Carrie Simms, PhD is a Principal Scientist, Bioprocess R&D, at Pfizer. She joined Pfizer 2.5 years ago and currently a member of the Nucleic Acids Medicines technology development team in Bioprocess R&D. Completed a PhD in Molecular Biology and Biochemistry at Simon Fraser University in Canada followed by post-doctoral training in RNA biochemistry, studying the effects of RNA damage on translation. Additional industry experience at Fimbrion therapeutics, a St Louis biotech focused on development of alternatives to traditional antibiotics.Read more

Read more about Carrie Simms

Ed Wong

Ed Wong is a Principal Scientist in Pivotal Biologics Drug Substance Development at Amgen Inc. He earned his BS degrees in chemical and biomedical engineering from Carnegie Mellon University and PhD in chemical engineering from the University of Virginia. He has extensive experience in cell culture and purification process development, for both mammalian and microbial expression systems, and protein characterization. At Amgen, he has advanced antibodies, multi-specifics, siRNAs, and vaccines, through various stages of clinical development and...Read more